PCVX earnings date and history (2026)
Vaxcyte Inc. (PCVX) has no scheduled report date on the calendar yet. Its last report, on Tue Nov 3, came in at -$1.56 against a -$1.84 consensus. Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s timing is established — the earnings calendar, the time the company filed its earnings release with the SEC and the day’s trading volume, by majority.
| Date | Est | Actual | Move |
|---|---|---|---|
| Nov 3, 2026 | -$1.84 | -$1.56 | — |
| Aug 5, 2026 | -$1.47 | -$1.97 | +5.3% |
| May 6, 2026 | -$1.86 | -$2.30 | -9.8% |
| Feb 24, 2026 | -$1.46 | -$1.80 | +2.8% |
| Nov 4, 2025 | -$1.27 | -$1.56 | -2.5% |
| Aug 6, 2025 | -$1.12 | -$1.22 | -9.1% |
| May 7, 2025 | -$1.02 | -$1.04 | +8.4% |
| Feb 25, 2025 | -$1.32 | -$1.02 | -0.9% |
| Nov 5, 2024 | -$0.98 | -$0.83 | -3.2% |
| Aug 6, 2024 | -$1.14 | -$1.10 | -4.6% |
| May 8, 2024 | -$1.11 | -$0.85 | -1.8% |
| Feb 27, 2024 | -$0.90 | -$1.82 | -7.3% |
| Nov 6, 2023 | -$0.79 | -$0.91 | +4.1% |
| Aug 8, 2023 | -$0.67 | -$0.70 | -3.9% |
| May 8, 2023 | -$0.80 | -$0.70 | +4.8% |
| Feb 27, 2023 | -$0.84 | -$0.73 | -3.1% |
| Nov 7, 2022 | -$0.80 | -$0.93 | +3.3% |
| Aug 8, 2022 | -$0.69 | -$0.80 | +0.4% |
| May 9, 2022 | -$0.56 | -$0.68 | +0.5% |
| Feb 28, 2022 | -$0.46 | -$0.54 | +2.9% |
| Nov 10, 2021 | -$0.47 | -$0.51 | — |
| Aug 11, 2021 | -$0.46 | -$0.46 | +4.6% |
About this data#
Report dates, sessions, consensus EPS estimates, reported EPS and surprises are third-party figures, subject to change, and may not be accurate. A quarter whose session is known is shown with it; for one whose session is not, the move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- Did PCVX beat earnings last quarter?
- Yes: on Tue Nov 3 PCVX reported -$1.56 against a -$1.84 consensus.